Skip to main content
Home
  • Australia
  • Austria
  • Belgium
  • Brazil
  • Chile
  • China
  • Colombia
  • France
  • Germany
  • India
  • Italy
  • Japan
  • Korea
  • Mexico
  • Netherlands
  • South Africa
  • Spain
  • Switzerland
  • Taiwan
  • United Kingdom
  • USA
  • Contact
  • English
  • French
GBT €8.96
  • Our Group
    • Guerbet in a nutshell
    • Our Corporate Responsibilities
    • Corporate Governance
    • Intrasense and Guerbet
      • Intrasense, a Guerbet Group subsidiary: Innovating in AI together
    • Careers
  • Products & Solutions
    MRI
    • Home of MRI Innovations
    • Artirem®
    • Dotarem®
    • Elucirem™ (Gadopiclenol)
    • Injectors, Accessories & Consumables
    • MRI Accessories
    • Consumables for Diagnostic Imaging
    • OptiStar® Elite
    • Ready-Box
    • Service & Support
    • OptiProtect™ 3S
    Diagnostic Imaging Interconnected Solutions…

    UNIK: Diagnostic Imaging Interconnected Solutions

    Explore our Solutions
    CT
    • Home of MRI Innovations
    • Conray® / Cysto-Conray®
    • Micropaque® / Microtrast®
    • Optiray®
    • Telebrix® Gastro
    • Xenetix® / ScanBag® by Xenetix®
    • Injectors, Accessories & Consumables
    • Consumables for Diagnostic Imaging
    • OptiBolus®
    • OptiOne™
    • OptiVantage™ Multi-use
    • OptiVantage™ Single-use
    • Ready-Box
    • Service & Support
    • OptiProtect™ 3S
    Diagnostic Imaging Interconnected Solutions…

    UNIK: Diagnostic Imaging Interconnected Solutions

    Explore our Solutions
    Cath Lab
    • Home of MRI Innovations
    • Optiray®
    • Xenetix® / ScanBag® by Xenetix®
    • Injectors, Accessories & Consumables
    • Consumables for Diagnostic Imaging
    • Illumena® Néo
    • Ready-Box
    • Service & Support
    • OptiProtect™ 3S
    Diagnostic Imaging Interconnected Solutions…

    UNIK: Diagnostic Imaging Interconnected Solutions

    Explore our Solutions
    Interventional Radiology
    • Pharmaceutical Drugs
    • Lipiodol® Ultra Fluid
    • Medical Devices
    • Qitexio®
    Solutions d’imagerie interventionnelle

    Interventional Imaging Solutions

    Explore our Solutions
    Women's Health
    • Pharmaceutical Drugs
    • Patent Blue V
    • Lipiodol® Ultra Fluid
    Fertility and women's health

    Women’s Health

    Explore our Solutions
  • Investors
    • Key Figures
    • Stock Performance
    • Financial Policy
    • Presentations, Reports & Regulated information
    • Agenda
    • General Meetings
  • Media
  • Educational Resources
  • Patient Resources
    • Blue November
    • Liver Cancer Awareness Month
    • Osteoarthritis
    • Vascular embolization
  • 100 years
    • Celebrating 100 years
    • Guerbet Saga

Media

Welcome to Guerbet Media section for journalists. The press releases are intended for their professional use. Find our latest press releases and our media resources.

Media…
  1. Homepage
  2. Media

Our Latest Press Releases

Intrasense and Guerbet announce PMDA certification in Japan for DUOnco™ Pancreas, an AI software designed to support the reading of pancreatic areas on contrast-enhanced CT

Read the article

Changes to the Composition of Guerbet’s Board of Directors

Read the article

Guerbet announces an important milestone achievement in the “Vascular Embolization” indication for Lipiodol® Ultra Fluid (Iodinated ethyl esters of fatty acids of poppy seed oil)

Read the article
Guerbet announces a strategic partnership with InterSystems to extend the deployment of Contrast&Care®

Guerbet announces a strategic partnership with InterSystems to extend the deployment of Contrast&Care®

Read the article
2018 revenue

2018 revenue

Read the article
2019 half-year results

2019 half-year results

Read the article

Revenue at 30 June 2019

Read the article
Guerbet high in the Gaïa Index for the 2nd year running

Guerbet high in the Gaïa Index for the 2nd year running

Read the article
2019 half-year results

2018 annual results

Read the article
Guerbet to present its innovative solution offering for interventional imaging at CIRSE 2019 Barcelona from September 7-11, 2019

ET 2019: Guerbet to participate at the European Conference on Embolotherapy

Read the article
NUCLIDIUM and Guerbet Form Strategic Partnership to Support the Advancement of targeted Copper-based Radiotheranostics

NUCLIDIUM and Guerbet Form Strategic Partnership to Support the Advancement of targeted Copper-based Radiotheranostics

Read the article
  • ‹
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • Current page13
Image
Logo Guerbet
  • Legal Information
  • Cookie Policy
  • Data Protection Policy
  • Patents
  • Contact
Copyright © Guerbet
2026
  • LinkedIn
  • Twitter
  • Instagram
  • YouTube